Anzu Special Acquisition Corp I (ANZUW) Stock Price, News & Analysis

Company Overview

Anzu Special Acquisition Corp. I was a special purpose acquisition company, or SPAC, formed to identify and complete a business combination with a private company. As a blank-check company, it did not have significant operating activities, products or services of its own before completing a transaction.

Anzu announced a business combination with Envoy Medical, a medical-device company developing fully implantable hearing solutions. Envoy Medical’s technologies are designed to address hearing loss through implantable devices, including the fully implanted Acclaim cochlear implant system.

The transaction was completed in 2023, after which the combined company operated under the Envoy Medical name. Anzu Special Acquisition Corp. I’s publicly traded warrants were associated with the SPAC structure and provided holders with the potential right to purchase shares under specified terms.

Key Stats

• Today's Range: $0.03 to $0.04
• 50-Day Range: $0.03 to $0.06
• 52-Week Range: $0.00 to $0.15
• Volume: 11,990 shs
• Average Volume: 32,101 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ANZUW
• CIK: 1840877
• Web: www.envoymedical.com
• Phone: (651) 361-8000
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A